Union européenne -
français -
EMA (European Medicines Agency)
azacitidine celgene
celgene europe bv - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - agents antinéoplasiques - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
Canada -
français -
Health Canada
thalomid capsule
celgene inc - thalidomide - capsule - 150mg - thalidomide 150mg - immunomodulatory agents
Canada -
français -
Health Canada
reblozyl poudre pour solution
celgene inc - luspatercept - poudre pour solution - 25mg - luspatercept 25mg - hematopoietic agents
Canada -
français -
Health Canada
reblozyl poudre pour solution
celgene inc - luspatercept - poudre pour solution - 75mg - luspatercept 75mg - antianemia drugs
Canada -
français -
Health Canada
abecma suspension
celgene inc - idécabtagène vicleucel - suspension - 520000000cellules - idécabtagène vicleucel 520000000cellules - gene therapy
Canada -
français -
Health Canada
idhifa comprimé
celgene inc - ÉnasidÉnib (mesylate d'ÉnasidÉnib) - comprimé - 50mg - ÉnasidÉnib (mesylate d'ÉnasidÉnib) 50mg - antineoplastic agents
Canada -
français -
Health Canada
idhifa comprimé
celgene inc - ÉnasidÉnib (mesylate d'ÉnasidÉnib) - comprimé - 100mg - ÉnasidÉnib (mesylate d'ÉnasidÉnib) 100mg - antineoplastic agents
Canada -
français -
Health Canada
onureg comprimé
celgene inc - azacitidine - comprimé - 300mg - azacitidine 300mg - antineoplastic agents
Canada -
français -
Health Canada
breyanzi suspension
celgene inc - lisocabtagène maraleucel - suspension - 120000000cellules - lisocabtagène maraleucel 120000000cellules
Union européenne -
français -
EMA (European Medicines Agency)
thalidomide bms (previously thalidomide celgene)
bristol-myers squibb pharma eeig - la thalidomide - le myélome multiple - immunosuppresseurs - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.